186 related articles for article (PubMed ID: 9566961)
1. Identification of two regions in apolipoprotein B100 that are exposed on the cytosolic side of the endoplasmic reticulum membrane.
Du X; Stoops JD; Mertz JR; Stanley CM; Dixon JL
J Cell Biol; 1998 May; 141(3):585-99. PubMed ID: 9566961
[TBL] [Abstract][Full Text] [Related]
2. Cytosolic components are required for proteasomal degradation of newly synthesized apolipoprotein B in permeabilized HepG2 cells.
Sakata N; Stoops JD; Dixon JL
J Biol Chem; 1999 Jun; 274(24):17068-74. PubMed ID: 10358059
[TBL] [Abstract][Full Text] [Related]
3. The amino-terminal domain of apolipoprotein B does not undergo retrograde translocation from the endoplasmic reticulum to the cytosol. Proteasomal degradation of nascent apolipoprotein B begins at the carboxyl terminus of the protein, while apolipoprotein B is still in its original translocon.
Liang S; Wu X; Fisher EA; Ginsberg HN
J Biol Chem; 2000 Oct; 275(41):32003-10. PubMed ID: 10922368
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein B-100 destined for lipoprotein assembly and intracellular degradation undergoes efficient translocation across the endoplasmic reticulum membrane.
Ingram MF; Shelness GS
J Lipid Res; 1996 Oct; 37(10):2202-14. PubMed ID: 8906597
[TBL] [Abstract][Full Text] [Related]
5. Topography of apolipoprotein B in subcellular fractions of rabbit liver probed with a panel of monoclonal antibodies.
Wilkinson J; Higgins JA; Groot P; Gherardi E; Bowyer D
J Lipid Res; 1993 May; 34(5):815-25. PubMed ID: 7685371
[TBL] [Abstract][Full Text] [Related]
6. Distribution, transport, and degradation of apolipoprotein B-100 in HepG2 cells.
Sakata N; Phillips TE; Dixon JL
J Lipid Res; 2001 Dec; 42(12):1947-58. PubMed ID: 11734567
[TBL] [Abstract][Full Text] [Related]
7. Intrahepatic assembly of very low density lipoproteins: immunologic characterization of apolipoprotein B in lipoproteins and hepatic membrane fractions and its intracellular distribution.
Davis RA; Prewett AB; Chan DC; Thompson JJ; Borchardt RA; Gallaher WR
J Lipid Res; 1989 Aug; 30(8):1185-96. PubMed ID: 2475561
[TBL] [Abstract][Full Text] [Related]
8. Regulated Co-translational ubiquitination of apolipoprotein B100. A new paradigm for proteasomal degradation of a secretory protein.
Zhou M; Fisher EA; Ginsberg HN
J Biol Chem; 1998 Sep; 273(38):24649-53. PubMed ID: 9733761
[TBL] [Abstract][Full Text] [Related]
9. Asymmetric distribution of pause transfer sequences in apolipoprotein B-100.
Kivlen MH; Dorsey CA; Lingappa VR; Hegde RS
J Lipid Res; 1997 Jun; 38(6):1149-62. PubMed ID: 9215543
[TBL] [Abstract][Full Text] [Related]
10. Co-translational interactions of apoprotein B with the ribosome and translocon during lipoprotein assembly or targeting to the proteasome.
Pariyarath R; Wang H; Aitchison JD; Ginsberg HN; Welch WJ; Johnson AE; Fisher EA
J Biol Chem; 2001 Jan; 276(1):541-50. PubMed ID: 11022045
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of intrahepatic membrane-bound and secretory apolipoprotein B by monoclonal antibodies: membrane-bound apolipoprotein B is more glycosylated.
Wong L; Torbati A
Biochemistry; 1994 Feb; 33(7):1923-9. PubMed ID: 8110797
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin-dependent and -independent proteasomal degradation of apoB associated with endoplasmic reticulum and Golgi apparatus, respectively, in HepG2 cells.
Liao W; Chang BH; Mancini M; Chan L
J Cell Biochem; 2003 Aug; 89(5):1019-29. PubMed ID: 12874835
[TBL] [Abstract][Full Text] [Related]
13. Regulated intracellular degradation of apolipoprotein B in semipermeable HepG2 cells.
Adeli K
J Biol Chem; 1994 Mar; 269(12):9166-75. PubMed ID: 8132654
[TBL] [Abstract][Full Text] [Related]
14. Proteasome-mediated degradation of apolipoprotein B targets both nascent peptides cotranslationally before translocation and full-length apolipoprotein B after translocation into the endoplasmic reticulum.
Liao W; Yeung SC; Chan L
J Biol Chem; 1998 Oct; 273(42):27225-30. PubMed ID: 9765244
[TBL] [Abstract][Full Text] [Related]
15. Apoprotein B100, an inefficiently translocated secretory protein, is bound to the cytosolic chaperone, heat shock protein 70.
Zhou M; Wu X; Huang LS; Ginsberg HN
J Biol Chem; 1995 Oct; 270(42):25220-4. PubMed ID: 7559659
[TBL] [Abstract][Full Text] [Related]
16. Regional specificities of monoclonal anti-human apolipoprotein B antibodies.
Krul ES; Kleinman Y; Kinoshita M; Pfleger B; Oida K; Law A; Scott J; Pease R; Schonfeld G
J Lipid Res; 1988 Jul; 29(7):937-47. PubMed ID: 2457642
[TBL] [Abstract][Full Text] [Related]
17. Intracellular assembly and degradation of apolipoprotein B-100-containing lipoproteins in digitonin-permeabilized HEP G2 cells.
Adeli K; Wettesten M; Asp L; Mohammadi A; Macri J; Olofsson SO
J Biol Chem; 1997 Feb; 272(8):5031-9. PubMed ID: 9030566
[TBL] [Abstract][Full Text] [Related]
18. Effects of tocotrienol on the intracellular translocation and degradation of apolipoprotein B: possible involvement of a proteasome independent pathway.
Wang Q; Theriault A; Gapor A; Adeli K
Biochem Biophys Res Commun; 1998 May; 246(3):640-3. PubMed ID: 9618265
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein B is synthesized in selected human non-hepatic cell lines but not processed into mature lipoprotein.
Dixon JL; Biddle J; Lo CM; Stoops JD; Li H; Sakata N; Phillips TE
J Histochem Cytochem; 2002 May; 50(5):629-40. PubMed ID: 11967274
[TBL] [Abstract][Full Text] [Related]
20. Efficient glycosylation site utilization by intracellular apolipoprotein B. Implications for proteasomal degradation.
Huang XF; Shelness GS
J Lipid Res; 1999 Dec; 40(12):2212-22. PubMed ID: 10588947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
